How do you pay?

How to pay the least

Ask for the cash price

Iclusig

We didn’t find one.

What to do

  1. Ask your pharmacy for Iclusig’s cash price, and one or two other pharmacies too.
  2. Iclusig’s savings card works only with insurance from a job or one you bought.

Other ways

Free from the maker, if you qualify Takeda Oncology Patient Assistance Program (Takeda Oncology Here2Assist). To be eligible for the Patient Assistance Program, patients must meet certain financial and insurance coverage criteria. Or call 1-844-817-6468 (Option 2).

See if you qualify 

Compare every option

Brand name

Iclusig, the original

Cash priceAsk the pharmacy
Ways to save on Iclusig

The maker’s card

Takeda Oncology Co-Pay Assistance Program

Savings card from Takeda

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on iclusig.com 

Or call 1-844-817-6468.

In the maker’s words

“You could pay as little as $0 per prescription…”

From the maker’s offer on iclusig.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

We didn’t find one.

Not soldNone found

What it’s used for

What the FDA label says

ICLUSIG is a kinase inhibitor indicated for the treatment of adult patients with:

Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

  • Newly diagnosed Ph+ ALL, in combination with chemotherapy. This indication is approved under accelerated approval based on minimal residual disease (MRD)-negative complete remission (CR) at the end of induction. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s).
  • As monotherapy in Ph+ ALL for whom no other kinase inhibitors are indicated or T315I-positive Ph+ ALL.

Chronic Myeloid Leukemia (CML)

  • Chronic phase (CP) CML with resistance or intolerance to at least two prior kinase inhibitors.
  • Accelerated phase (AP) or blast phase (BP) CML for whom no other kinase inhibitors are indicated.
  • T315I-positive CML (chronic phase, accelerated phase, or blast phase).

Limitations of Use: ICLUSIG is not indicated and is not recommended for the treatment of patients with newly diagnosed CP-CML.

Source: the FDA label for Iclusig (Takeda Pharmaceuticals America, Inc.), August 14, 2026. Full label on DailyMed 

Good to know

  • “Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
  • Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.